Neuropathic pain: a practical guide for the clinician

Gilron, Ian; Watson, C. Peter N.; Cahill, Catherine M.; Moulin, Dwight E.
August 2006
CMAJ: Canadian Medical Association Journal;8/1/2006, Vol. 175 Issue 3, p265
Academic Journal
Neuropathic pain, caused by various central and peripheral nerve disorders, is especially problematic because of its severity, chronicity and resistance to simple analgesics. The condition affects 2%-3% of the population, is costly to the health care system and is personally devastating to the people who experience it. The diagnosis of neuropathic pain is based primarily on history (e.g., underlying disorder and distinct pain qualities) and the findings on physical examination (e.g., pattern of sensory disturbance); however, several tests may sometimes be helpful. Important pathophysiologic mechanisms include sodium- and calcium-channel upregulation, spinal hyperexcitability, descending facilitation and aberrant sympathetic--somatic nervous system interactions. Treatments are generally palliative and include conservative nonpharmacologic therapies, drugs and more invasive interventions (e.g., spinal cord stimulation). Individualizing treatment requires consideration of the functional impact of the neuropathic pain (e.g., depression, disability) as well as ongoing evaluation, patient education, reassurance and specialty referral. We propose a primary care algorithm for treatments with the most favourable risk--benefit profile, including topical lidocaine, gabapentin, pregabalin, tricyclic antidepressants, mixed serotonin--norepinephrine reuptake inhibitors, tramadol and opioids. The field of neuropathic pain research and treatment is in the early stages of development, with many unmet goals. In coming years, several advances are expected in the basic and clinical sciences of neuropathic pain, which will provide new and improved therapies for patients who continue to experience this disabling condition.


Related Articles

  • Neuropathic Pain in Cancer Patients—Prevalence and Management in a Tertiary Care Anesthesia-Run Referral Clinic Based in Urban India. Bhatnagar, Sushma; Mishra, Seema; Roshni, S.; Gogia, Vikas; Khanna, Sandeep // Journal of Palliative Medicine;Jul2010, Vol. 13 Issue 7, p819 

    Background: Cancer pain is often intractable and has a considerable impact on the quality of life. Nociceptive pain is easily recognized and managed using conventional analgesics. The neuropathic component makes cancer pain difficult to manage. The epidemiology of neuropathic pain in cancer...

  • Sodium Channel Blockers in Neuropathic Pain. Kalso, Eija // Current Pharmaceutical Design;Sep2005, Vol. 11 Issue 23, p3005 

    Subtypes of tetrodotoxin resistant voltage-gated sodium channels are involved in the development of certain types of neuropathic pains. After nerve injury hyperexcitability and spontaneous firing develop at the site of injury and also in the dorsal root ganglion cell bodies. This...

  • Topical Analgesics in Neuropathic Pain. Sawynok, Jana // Current Pharmaceutical Design;Sep2005, Vol. 11 Issue 23, p2995 

    Neuropathic pain can be difficult to treat clinically, as current therapies involve partial effectiveness and significant adverse effects. Following the development of preclinical models for neuropathic pain, significant advances have been made in understanding the neurobiology of neuropathic...

  • Depression in palliative care.  // Nursing Standard;11/26/2008, Vol. 23 Issue 12, p58 

    A questionnaire regarding depression in palliative care is presented.

  • Depression in palliative care: a systematic review. Part 2. Treatment. Lan Ly, Kelly; Addington-Hall, Julia; Chidgey, Jayne; Hotopf, Matthew // Palliative Medicine;Jul2002, Vol. 16 Issue 4, p279 

    Objective: To summarize available literature containing data on the treatment of depression in palliative care patients. Methods: A systematic review was conducted using extensive electronic databases and hand searches. All randomized controlled trials (RCTs) of interventions for depression in...

  • Neurological face of palliative care-A bitter truth for the neurologist. Syam, U.; Rajagopal; Nirmala; Baburaj // Annals of Indian Academy of Neurology;Nov2008 Supplement, Vol. 11, pS136 

    Objectives: This study was undertaken to study. 1. The incidence of neurological problems among patients receiving palliative care, 2. Beneficial effects of intervention by a neurologist in a palliative care team. Methods: All patients (both new and old) which included inpatients, outpatients...

  • Palliative Care in Neurological Disease: A Team Approach. Sander, Ruth // Nursing Older People;Sep2010, Vol. 22 Issue 7, p8 

    The article reviews the book "Palliative Care in Neurological Disease: A Team Approach," edited by Judi Byrne et al.

  • Which depression screening tools should be used in palliative care? Lloyd-Williams, Mari; Spiller, Juliet; Ward, Jason // Palliative Medicine;Jan2003, Vol. 17 Issue 1, p40 

    Depression is a significant symptom for many palliative care patients, but is difficult to diagnose and therefore treat. In an effort to improve detection, there has been increasing interest in the use of screening tools. Many tools, however, have been developed for physically well patients and...

  • Diarrhea in Palliative Care. Alderman, Jeffrey // Journal of Palliative Medicine;Apr2005, Vol. 8 Issue 2, p449 

    Provides information on diarrhea in palliative care. Definition and common causes of diarrhea; Factors to consider when performing a physical examination; Use of antibiotics.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics